Nonalcoholic fatty liver disease: an agenda for clinical research

Gender differences in stigma and care avoidance among people living with MASLD: an international survey.

JHEP reports : innovation in hepatology·2026

The mechanics of liver regeneration.

Science (New York, N.Y.)·2026

Disrupted Mitochondrial Copper Homeostasis Promotes Ferroptotic Stress, Senescence and MASLD Progression.

bioRxiv : the preprint server for biology·2026

The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver disease.

Nature communications·2026

A unimolecular GLP-1 and FGF21 dual agonist for treatment of metabolic dysfunction-associated steatohepatitis.

Communications medicine·2026

Vitamin E dosing study (VEDS) in patients with metabolic dysfunction-associated steatotic liver disease with elevated aminotransferases: A multicenter, randomized, placebo-controlled trial.

Hepatology (Baltimore, Md.)·2026

The hepatic sinusoid as a regulatory niche: From cellular specialization to precision hepatology.

Hepatology (Baltimore, Md.)·2026

Safety and efficacy of zetomipzomib in relapsed or insufficiently responding autoimmune hepatitis: Results from the randomized, double-blind, placebo-controlled, phase 2a PORTOLA study and open-label extension.

Hepatology (Baltimore, Md.)·2026

Hepatitis B virus proteome analysis identifies apolipoprotein C1 facilitating particle production and virus entry.

Hepatology (Baltimore, Md.)·2026

Lactulose with or without TeleTai-Chi for the prevention of falls: A sequential multiple assignment randomized controlled trial (LiveSMART).

Hepatology (Baltimore, Md.)·2026

VPS13D protects against alcohol- associated steatohepatitis by regulating organelle contacts and VLDL secretion.

Hepatology (Baltimore, Md.)·2026

Clinical utility of a 30% reduction in VCTE-derived liver stiffness measurement for identifying histologic improvement in MASH.

Hepatology (Baltimore, Md.)·2026

Type 2 Angiotensin II receptor (AT2R) deficiency exacerbates cardiac senescence and fibrosis in aging mice.

Clinical science (London, England : 1979)·2026

Dual Effects of β-TrCP2 Deletion in Bone Homeostasis: Suppression of Osteoclastogenesis and Enhancement of Osteoblast Activity.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Doxorubicin-Induced Myocardial Cytotoxicity Is Associated with the Downregulation of the Klotho-Nuclear Factor Erythroid 2-Related Factor 2 Signaling Pathway.

Cardiology·2026

Integrated proteomic-transcriptomic profiling identifies NR3C2 up-regulation and a candidate plasma-protein-handling signature in chronic podocyte injury.

The FEBS journal·2026

Survival of Patients With MBD4-Mutated Metastatic Uveal Melanoma Treated With Immune Checkpoint Inhibitors.

Translational vision science & technology·2026

Tozuleristide Fluorescence-Guided Resection of Gliomas: Results of a Phase II Investigator-Initiated Study.

Operative neurosurgery (Hagerstown, Md.)·2026

Related Experiment Videos

Nonalcoholic fatty liver disease: an agenda for clinical research

Related Concept Videos

Gender differences in stigma and care avoidance among people living with MASLD: an international survey.

The mechanics of liver regeneration.

Disrupted Mitochondrial Copper Homeostasis Promotes Ferroptotic Stress, Senescence and MASLD Progression.

The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver disease.

A unimolecular GLP-1 and FGF21 dual agonist for treatment of metabolic dysfunction-associated steatohepatitis.

Vitamin E dosing study (VEDS) in patients with metabolic dysfunction-associated steatotic liver disease with elevated aminotransferases: A multicenter, randomized, placebo-controlled trial.

The hepatic sinusoid as a regulatory niche: From cellular specialization to precision hepatology.

Safety and efficacy of zetomipzomib in relapsed or insufficiently responding autoimmune hepatitis: Results from the randomized, double-blind, placebo-controlled, phase 2a PORTOLA study and open-label extension.

Hepatitis B virus proteome analysis identifies apolipoprotein C1 facilitating particle production and virus entry.

Lactulose with or without TeleTai-Chi for the prevention of falls: A sequential multiple assignment randomized controlled trial (LiveSMART).

VPS13D protects against alcohol- associated steatohepatitis by regulating organelle contacts and VLDL secretion.

Clinical utility of a 30% reduction in VCTE-derived liver stiffness measurement for identifying histologic improvement in MASH.

Type 2 Angiotensin II receptor (AT2R) deficiency exacerbates cardiac senescence and fibrosis in aging mice.

Dual Effects of β-TrCP2 Deletion in Bone Homeostasis: Suppression of Osteoclastogenesis and Enhancement of Osteoblast Activity.

Doxorubicin-Induced Myocardial Cytotoxicity Is Associated with the Downregulation of the Klotho-Nuclear Factor Erythroid 2-Related Factor 2 Signaling Pathway.

Integrated proteomic-transcriptomic profiling identifies NR3C2 up-regulation and a candidate plasma-protein-handling signature in chronic podocyte injury.

Survival of Patients With MBD4-Mutated Metastatic Uveal Melanoma Treated With Immune Checkpoint Inhibitors.

Tozuleristide Fluorescence-Guided Resection of Gliomas: Results of a Phase II Investigator-Initiated Study.

Related Experiment Videos

Nonalcoholic fatty liver disease: an agenda for clinical research

Related Concept Videos

Related Articles